Triple-negative breast cancers (TNBC) are an heterogenous BC subtype that lack the expression of estrogen receptor (ER), progesterone receptor (PR), and epidermal growth factor receptor 2 (HER2). Here, ESR1 is linked to triple-negative breast carcinoma.